RXO Inc. price target lowered to $24 from $30 at Barclays

Barclays analyst Brandon Oglenski lowered the firm’s price target on RXO Inc. (RXO) to $24 from $30 and keeps an Overweight rating on the shares. Another year and another wait-and-see outlook for RXO, the firm says. Barclays notes that deterioration in core brokerage earnings following last year’s Coyote acquisition suggests a 20% lower 2025 earnings outlook, which likely explains the materially negative reaction in the company’s shares today.